Mineral and bone metabolism disorders in chronic kidney disease (CKD-MBD)constitute a syndrome defined by changes in calcium, phosphorus (P), vitaminD and parathormone, fibroblast growth factor 23 (FGF-23) and its specificcofactor, Klotho. This evidence concerns the gene KL and metabolic bone disorder.